Literature DB >> 18330598

MHC class I immune evasion in MCMV infection.

Carmen M Doom1, Ann B Hill.   

Abstract

Murine cytomegalovirus (MCMV) is a well-studied model of natural beta-herpesvirus infection. However, many questions remain regarding its control by and evasion of the immune response it generates. CD8 and CD4 T cells have both unique and redundant roles in control of the virus that differ based on the immunocompetence of the infected mice. MCMV encodes major histocompatibility complex (MHC) class I immune evasion genes that can have an impact in vitro, but their role in infection of immunocompetent mice has been difficult to identify. This review addresses the evidence for their in vivo function and suggests why they may be evolutionarily conserved.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18330598     DOI： 10.1007/s00430-008-0089-y

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


  78 in total

1.  Propagation of salivary gland virus of the mouse in tissue cultures.

Authors:  M G SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1954-07

2.  Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus.

Authors:  Diane M LoPiccolo; Marielle C Gold; Daniel G Kavanagh; Markus Wagner; Ulrich H Koszinowski; Ann B Hill
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection.

Authors:  L J Lathbury; J E Allan; G R Shellam; A A Scalzo
Journal:  J Gen Virol       Date:  1996-10       Impact factor: 3.891

4.  Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection.

Authors:  Michael W Munks; Kathy S Cho; Amelia K Pinto; Sophie Sierro; Paul Klenerman; Ann B Hill
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.

Authors:  Christian O Simon; Rafaela Holtappels; Hanna-Mari Tervo; Verena Böhm; Torsten Däubner; Silke A Oehrlein-Karpi; Birgit Kühnapfel; Angélique Renzaho; Dennis Strand; Jürgen Podlech; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

6.  The prevalence of viral antibodies during a large population fluctuation of house mice in Australia.

Authors:  G R Singleton; A L Smith; C J Krebs
Journal:  Epidemiol Infect       Date:  2000-12       Impact factor: 2.451

7.  Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions.

Authors:  Rafaela Holtappels; Natascha K A Grzimek; Christian O Simon; Doris Thomas; Doris Dreis; Matthias J Reddehase
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.

Authors:  Urs Karrer; Sophie Sierro; Markus Wagner; Annette Oxenius; Hartmut Hengel; Ulrich H Koszinowski; Rodney E Phillips; Paul Klenerman
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

9.  The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.

Authors:  Marielle C Gold; Michael W Munks; Markus Wagner; Ulrich H Koszinowski; Ann B Hill; Steven P Fling
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

10.  Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.

Authors:  J F Bukowski; J F Warner; G Dennert; R M Welsh
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307
View more
  39 in total

Review 1.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 2.  Oncomodulation by human cytomegalovirus: evidence becomes stronger.

Authors:  Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

3.  The efficacy of antigen processing is critical for protection against cytomegalovirus disease in the presence of viral immune evasion proteins.

Authors:  Rafaela Holtappels; Doris Thomas; Matthias J Reddehase
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

4.  The immune evasion paradox: immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation.

Authors:  Verena Böhm; Christian O Simon; Jürgen Podlech; Christof K Seckert; Dorothea Gendig; Petra Deegen; Dorothea Gillert-Marien; Niels A W Lemmermann; Rafaela Holtappels; Matthias J Reddehase
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

5.  Immune evasion proteins enhance cytomegalovirus latency in the lungs.

Authors:  Verena Böhm; Christof K Seckert; Christian O Simon; Doris Thomas; Angélique Renzaho; Dorothea Gendig; Rafaela Holtappels; Matthias J Reddehase
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

Review 6.  True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity.

Authors:  Edward S Mocarski; William J Kaiser; Devon Livingston-Rosanoff; Jason W Upton; Lisa P Daley-Bauer
Journal:  J Immunol       Date:  2014-03-01       Impact factor: 5.422

7.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

Review 8.  Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved.

Authors:  Carine Savarin; Cornelia C Bergmann
Journal:  Curr Opin Pharmacol       Date:  2008-06-16       Impact factor: 5.547

9.  Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.

Authors:  Niels A W Lemmermann; Kerstin Gergely; Verena Böhm; Petra Deegen; Torsten Däubner; Matthias J Reddehase
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

10.  Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes.

Authors:  Lisa P Daley-Bauer; Grace M Wynn; Edward S Mocarski
Journal:  Immunity       Date:  2012-07-27       Impact factor: 31.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.